Acute aspirin (ASA)
PreclinicalSmall molecule
Acute aspirin (ASA) is one of 4 small molecule programs targeting Aspirin. It is currently in Preclinical.
1
Indications
1
Total Trials
0
Active Trials
3
Competitors
Pipeline
Status by Indication[3][1]
Competition
Competitive Landscape
4 competitors in Aspirin
#DrugCompanyPhaseTrials
1Bayer Aspirin
BayerApproved
Acetylsalicylic Acid
BayerPhase 3
Celebrex
PPhiladelphia Eye Associates
Phase 1
Acute aspirin (ASA)
DDave Hostler
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Acute aspirin (ASA). EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details
Drug Info
Quick Facts
- Modality
- Small molecule[2]
- Highest Phase
- Preclinical[1]
- Company
- DDave Hostler